Fluvoxamine inhibits the CYP2C19-catalysed metabolism of proguanil in vitro

The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

H.K. Crewe, MS Lennard, GT Tucker et al. · British Journal of Clinical Pharmacology · 1992 · 471 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen et al. · Biochemical Pharmacology · 1993 · 372 citations

Medicine, Pharmacokinetics, Pharmacology +13

Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans

Jorge Goldstein, M B Faletto, M Romkes-Sparks et al. · Biochemistry · 1994 · 363 citations

Medicine, Biochemistry, Pharmacology +10

Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.

Martine Bourrié, Viviane Meunier, Yves Berger et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 362 citations

Medicine, Biochemistry, Pharmacology +15

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

U. Jeppesen, L. F. Gram, Kirsten Vistisen et al. · European Journal of Clinical Pharmacology · 1996 · 321 citations

Medicine, Pharmacokinetics, Pharmacology +12